medigraphic.com

2006, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2006; 44 (1)

Diabetes Mellitus in Adult Population of IMSS. Results of the National Health Survey 2000

Vázquez-Martínez JL, Gómez-Dantés H, Fernández-Cantón S

Language: Spanish
References: 66
Page: 13-26
PDF size: 222.17 Kb.


ABSTRACT

Objective: to describe the prevalence and control of diabetes in the adult population served by the Instituto Mexicano del Seguro Social accord-ing to data from the National Health Survey 2000 (ENSA-2000).
Material and methods: the data for adults from the National Health Survey 2000 was used to estimate and describe the prevalence of diabetes in the population that belongs to the social security system in Mexico. Criteria used to define diabetes mellitus were the medical diagnosis of the disease (MDDM) and the glucose measurement from capillary blood (›126 mg/dL fasting sample and 200 mg/dL in casual blood sample). If diabetes was confirmed only through blood sample, the diabetes case was define as survey finding (SF). Prevalences were estimated for both groups, while means and medians were estimated for the four possible combination groups (SF+, MDDM+, SF+, MDDM-, SF-, MDDM+, SF-, MDDM-). Sampling results were adjusted for population estimates according to the methods established in the ENSA-2000. Diabetes is described according to age, sex, education level, geographic region, background of diabetes in the family, body mass index (BMI), abdominal perimeter. A logistic regression method was used to estimate potential associations with different risk factors.
Results: overall prevalence was 8.7 %; for MDDM, it was 7.1 %, and for SF, only 1.5 %. Glycemia was highest in SF+ and MDDM-, median 292 mg/dL and in MDDM+ but SF-, median 289 mg/dL. Major risk factors were background of diabetes in both parents, abdominal obesity, low edu-cational level age (coef. = 0.5943 per decade) and BMI (coef. = 0.0133).
Conclusions: diabetes in social security popu-lation is higher than in the rest of the population, while genetic background, age, educational level, high BMI and abdominal perimeter have important influences in diabetes prevalence in this population. Glucose control is suboptimal even in patients under medical supervision.


REFERENCES

  1. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, Olaiz G, Valles V, Ríos-Torres JM, et al. Early onset type 2 diabetes in a Mexican nationwide survey. Am J Med 2002;113:569-574.

  2. 2. Secretaría de Salud. En dónde estamos. La salud y los servicios de salud en México. Programa Nacional de Salud. México: Secretaría de Salud; 2003. p. 25-51.

  3. 3. Uauy R, Abala C, Kain J. Obesity trends in Latin America: transiting from under-to overweight. J Nutr 2001;131:893S-899S.

  4. 4. Jiménez-Cruz A, Bacardí-Gascón M, Jones EG. Consumption of fruits, vegetables; soft drinks, and high-fat-containing snacks; Mexican food survey. Arch Med Res 2002;33(1):74-80.

  5. 5. Dixon LB, Sundquist J, Winkleby M. Differences in energy, nutrient, and food intakes in a US sample of Mexican-American women and men: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2000;15;152(6):548-557.

  6. 6. Otiniano ME, Du X, Ottenbacher K, Black SA, Markides KS. Lower extremity amputations in diabetic Mexican American elders: incidence, prevalence and correlates. J Diabetes Complications 2003;17(2):59-65.

  7. 7. Centers for Disease Control and Prevention. Lower extremity amputation episodes among persons with diabetes-New Mexico, 2000. MMWR Morb Mortal Wkly Rep 2003;52(4):66-68.

  8. 8. Escobedo-de la Peña J, Rico-Verdín B. Incidence and fatality of the acute and chronic complications of diabetes mellitus in Mexico. Salud Publica Mex 1996;38(4):236-242.

  9. 9. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289(1):76-79.

  10. Escobedo-De la Peña J, Islas S, Lifshitz-Guinzberg A, Méndez JD, Revilla C, Vázquez-Estupiñán F. Higher prevalence of diabetes in hypertensive subjects with upper body fat distribution. Rev Invest Clin 1998;50:5-12.

  11. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-1053.

  12. Barceló A, Rajpathak S. Incidence and prevalence of diabetes mellitus in the Americas, Pan Am J Public Health 2001:10(5);300-308.

  13. Barceló A, Daroca M, Rivera R, Duarte E, Zapata A, Vorha M. Diabetes in Bolivia. Rev Panam Salud Publica 2001:10(5):318–323.

  14. Jiménez JT, Palacios M, Canete F, Barriocanal LA, Medina U, Figueredo R, et al. Prevalence of diabetes mellitus and associated cardiovascular risk factors in an adult urban population in Paraguay. Diabet Med 1998;15(4):334-338.

  15. Secretaría de Salubridad y Asistencia. Reporte de la Encuesta Nacional de Enfermedades Crónicas 1992. México: SSA; 1993. p. 19-24.

  16. Borges A, Gómez-Dantés H. Uso de los servicios de salud por la población de 60 años y más en México. Salud Publica Mex 1998;40:13-23.

  17. Castro V, Gómez-Dantés H, Negrete-Sánchez J, Tapia-Conyer R. Las enfermedades crónicas en las personas de 60 a 69 años. Salud Publica Mex 1996;38:438-447.

  18. Secretaría de Salud. Encuesta Nacional de Salud II. México: SSA; 1994. p. 17-20.

  19. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Tomo 2. La salud de los adultos. Cuernavaca, Morelos, México. Instituto Nacional de Salud Pública, 2003.

  20. Secretaría de Salud. Morbilidad, 2000. México. Secretaría de Salud; 2003. p. 25-51.

  21. Borges-Yáñez SA, Gómez-Dantés H, Gutiérrez-Robledo LM, Fabián-San Miguel G, Rodríguez R. Utilización de servicios hospitalarios por la población anciana de la Ciudad de México. Salud Publica Mex 1996;38:475-486.

  22. Instituto Nacional de Salud Pública. Atlas de la Salud 2002. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública; 2001. p. 31, 52.

  23. Secretaría de Salud. Salud México 2002. Infor-mación para la rendición de cuentas. México: Secretaría de Salud; 2003. p. 42-43.

  24. Barquera S, Tovar-Guzmán V, Campos-Nonato I, González-Villalpando C, Rivera-Dommarco J. Geography of diabetes mellitus mortality in Mexico: An epidemiologic transition analysis. Arch Med Res 2003. 34(5):407-414.

  25. División Técnica de Información Estadística en Salud. Principales causas de muerte en el grupo de edad general según sexo (total nacional 2002). México: Instituto Mexicano del Seguro Social; 2002.

  26. Evans CA, Fielding JE, Browson RC, et al. Strategies for reducing morbidity and mortality from diabetes through health-care system interventions and diabetes self-management education in community settings. MMWR 2001;50(RR16):1-15.

  27. Arredondo A, Zúñiga A. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case. Diabetes Care 2004;27(1):104-109.

  28. Arredondo A. Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003. Rev Invest Clin 2001;53(5): 422-429.

  29. Villarreal-Ríos E, Salinas-Martínez AM, Medina-Jáuregui A, Garza-Elizondo ME, Núnez-Rocha G, Chuy-Díaz ER. The cost of diabetes mellitus and its impact on health spending in Mexico. Arch Med Res 2000;31(5):511-4.

  30. Rascón-Pacheco RA, Santillana-Macedo MA, Romero-Arredondo ME, Rivera-Icedo BM, Romero-Cancio JA, Cota-Rembau AI. Sistema de vigilancia epidemiológica para el paciente diabético; el uso de tecnología computacional en la calidad de la atención médica. Salud Publica Mex 2000;42:324-332.

  31. Dunstan DW, Zimmet PZ, Welborn TA, de Courten MP, Cameron A, Sicree RA, et al. The rising prevalence of diabetes mellitus and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2000;25:829-834.

  32. Hernández-Ronquillo L, Téllez-Zenteno JF, Garduño-Espinoza J, González-Acevez E. Factors associated with therapy noncompliance in type-2 diabetes patients. Sal Publica Mex 2003;45:191-197.

  33. Gagliardino JJ, de la Hera M, Siri F. Evaluación de la calidad de la asistencia al paciente diabético en América Latina. Rev Panam Sal Publica 2001; 10(5):309-317.

  34. Rosas-Peralta M. Arterial hypertension in Mexico and its association with other risk factors Arch Cardiol Mex 2003;73(Suppl 1):S137-S140.

  35. Velázquez-Monroy O, Rosas-Peralta M, Lara-Esqueda A, Pastelín-Hernández G, Castillo C, Attie F. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo car-diovascular en México: resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2003;73: 62-77.

  36. Velásquez-Monroy O, Rosas-Peralta M, Lara-Ezqueda A, Pastelón-Hernández G. Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000.Arch Cardiol Mex 2002; 72(1): 71-84.

  37. Aguilar-Salinas CA, Velázquez Monroy O, Gómez-Pérez FJ. Characteristics of patients with type 2 diabetes in Mexico: Results from a large population-based nationwide survey. Diabetes Care 2003; 26(7):2021-2026.

  38. Hoaglin DC. Letter values: a set of selected order statistics. En: Hoaglin DC, Mosteller F, Tukey JW, editors. Understanding robust and exploratory data analysis. New York: John Wiley and Sons; 2000. p. 33-57.

  39. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.

  40. National Institute Health, National Heart, Lung and Blood Institute. Obesity education initiative; North American Association for the Study of Obesity. The practical guide to the identification, evaluation and treatment of overweight and obesity in adults. Bethesda, Maryland: NIH; 2000.

  41. Valdespino JL, Olaiz G, López-Barajas MP, Mendoza L, Palma O, Velázquez O, et al. Encuesta Nacional de Salud 2000. Tomo I. Vivienda, población y utilización de servicios de salud. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública; 2003.

  42. Rolka DB, Narayan KM, Thompson TJ, et al. Performance of recommended screening tests for undiagnosed diabetes and dysglycemia. Diabetes Care 2001;24(11):1899-1903.

  43. Hernández-Ávila M, Garrido F, Salazar-Martínez E. Sesgos en estudios epidemiológicos. Salud Publica Mex 2000;42(5):438-446.

  44. Yach D, Alberti G. Screening for type 2 diabetes. Report of a World Health Organization and International Diabetes Federation Meeting, WHO/NMH/MNC/03.1, Geneva, WHO 2003.

  45. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-24.

  46. Colagiuri S, Colagiuri R, Na'ati S, Muimuiheata S, Hussain Z, Palu T. The prevalence of diabetes in the kingdom of Tonga. Diabetes Care 2002;25: 1378-1383.

  47. Stern MP. Genetic and environmental influences on type 2 diabetes mellitus in Mexican Americans. Nutr Rev 1999; May 57(5 Pt 2):S66-S70.

  48. Chowdury T, Grace C, Kopelman P. Preventing diabetes in south Asians. BMJ 2003;327:1059-1060.

  49. Aguilar-Salinas CA, Reyes-Rodríguez E, Ordóñez-Sánchez ML, Torres MA, Ramírez-Jiménez S, Domínguez-López A, et al. Early-onset type 2 diabetes: metabolic and genetic characterization in the Mexican population. J Clin Endocrinol Metab 2001,86(1):220-226.

  50. Duggirala R, Blangero J, Almasy L, Dyer TD, Williams KL, Leach RJ, et al. Linkage of type 2 diabetes mellitus and age on onset to a genetic location on chromosome 10q in Mexican Americans. Am J Human Genet 1999;64:1127-1140.

  51. Pierce M, Keen H, Bradley C. Risk of diabetes in offspring of parents with non-insulin-dependent diabetes. Diabetic Medicine 1995;12:6-13.

  52. van der Sande MAB, Walraven GEL, Milligan PJM, Banya WAS, Ceesay SM, Nyan OA, MacAdam KPWJ. Family history: an opportunity for early interventions and improved control of hypertension, obesity and diabetes. Bull WHO 2001;79(4):321-328.

  53. González-Ortiz M, Martínez-Abundis E. Maternal effect of type 2 diabetes mellitus on insulin sensitivity and metabolic profile in healthy young Mexicans. Diabetes Nutr Metab 1999 Feb;12(1):32-36.

  54. Rodríguez-Morán M, Guerrero-Romero F. The parental phenotype of diabetes, but not of essential hypertension, is linked to the development of metabolic syndrome in Mexican individuals. Acta Diabetol 2001;38(2):87-91.

  55. Guerrero-Romero F, Rodríguez-Morán M. Dia-betes family history is associated with early insulin response, in healthy Hispanic-Mexican subjects. Gac Med Mex 200;137(6):529-534.

  56. Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study. Obes Res 1997;5(1):16-23.

  57. Berber A, Gómez-Santos R, Fanghanel G, Sánchez-Reyes L. Anthropometric indexes in the prediction of type 2 diabetes mellitus, hypertension and dyslipidaemia in a Mexican population. Int J Obes Relat Metab Disord 2001;25(12):1794-1799.

  58. Sánchez-Castillo CP, Velázquez-Monroy O, Berber A. Anthropometric cut-off points for predicting chronic diseases in the Mexican National Health Survey 2000. Obes Res 2003;11(3):442-451.

  59. Barceló A, Vovides Y. The Panamerican Health Organization and the World Diabetes Day. Pan Am J Public Health 2001;10(5):297-299.

  60. Oviedo-Mota MA, Espinosa-Larrañaga F, Reyes-Morales H, Trejo y Pérez JA, Gil-Velázquez E. Guía clínica para el diagnóstico y tratamiento de la dia-betes mellitus tipo 2. Rev Med IMSS 2003;41 (Supl):S27-S46.

  61. Wing R, Goldstein M, Acton JK, et al. Lifestyle changes related to obesity, eating behavior and physical activity, Diabetes Care 2001;24:117-123.

  62. Durán-Varela BR, Rivera-Chavira B, Franco. Pharmacological therapy compliance in diabetes. Salud Publica Mex 2001;43(3):233-236.

  63. Williamson DF, Thompson T, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight indivuduals with diabetes. Diabetes Care 2000;23:1499-1504.

  64. González-Villalpando C, González-Villalpando ME, Rivera-Martínez D, Stern MP. Incidence and progression of diabetic retinopathy in low income population of Mexico City Rev Invest Clin 1999; 51(3):141-150.

  65. Peña-Valdovinos A, Jiménez-Cruz A, Leyva-Pacheco R, Bacardí-Gascón M. Metabolic control in diabetic patients at the primary care level in Mexico. Diabetes Res Clin Pract 1997 Sep;37(3):179-184.

  66. Chin HM, Cook S, Jin L, et al, Barriers to providing diabetes care in community health centers. Diabetes Care 2001;24:268-274.




2020     |     www.medigraphic.com